See where youcan take the test
Offer EarlyCDT-Lung to your Patients
Assess lung cancer risk
The Company behind EarlyCDT-Lung
Health Diagnostic Laboratory, Inc. has acquired substantially all of the assets of Oncimmune USA LLC, the subsidiary of Oncimmune Ltd.
CLICK HERE FOR PRESS RELEASE
Oncimmune has established a Science Committee to lead and approve all of the workflow of the Company’s R&D department, ensuring that all research is clearly focused on the interests of the Company.
CLICK HERE FOR COMPANY STATEMENT
Find lung cancer before symptoms appear. EarlyCDT-Lung combined with CT can help.
Panel of autoantibodies to aid in early lung cancer detection
Recent NLST Trial further shows 20% mortality improvement. EarlyCDT-Lung can reduce false positives associated with CT.
How to identify the relatively small percentage of lung cancers (5-50 depending on the level of risk), per 1,000, that are present in your high-risk patient population. More….
Use of EarlyCDT-Lung:
EarlyCDT-Lung is a simple blood test which is ordered by a GP, or other suitably qualified medical professional, to aid in the risk assessment and early detection of lung cancer. More…
© 2014 Oncimmune Limited | Clinical Sciences Building | Nottingham City Hospital | Hucknall Rd. | Nottingham NG5 1PB | +44 (0) 115 82 31869